巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    虛擬市場

    Fulgent Genetics

    FLGT
    57.980
    ▲2.010
    ▲3.59%
    概況消息
    最少15分鐘延遲，股票資訊由第三方資訊供應商提供
    ・Fulgent Genetics - 延遲價格・最後更新於 27/05 12:14
    最高位
    58.800
    最低位
    56.110
    開市價
    --
    前收市價
    55.970
    成交量(千)
    18.81
    成交額(百萬)
    9.30
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    1,758.37
    市盈率
    3.920
    息率
    --
    差價
    --
    52週高低
    112.000 - 47.650
    所有資料不保證絕對正確、完整、或實時，僅作為參考使用。投資涉及風險，過往業績並不代表將來表現，作任何投資決定或交易前，閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Fulgent Genetics
    證券代碼
    FLGT.US
    所屬板塊
    Diagnostics & Research
    公司業務
    Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; Canada; and Other Countries.
    發行量
    30252511
    公司總部
    4978 Santa Anita Avenue
    公司網址
    https://www.fulgentgenetics.com
    公司電郵
    info@fulgentgenetics.com
    公司電話
    +1 626 350-0537

    最新發佈

    暫無內容

    關於

    Fulgent Genetics(FLGT.US)所屬的行業板塊為Diagnostics & Research。
    Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; Canada; and Other Countries.
    詳細公司背景可參考: https://www.fulgentgenetics.com。